Hypergastrinemia Is Associated with Increased Risk of Distal Colon Adenomas
Abstract
Background/Aims:Helicobacter pylori infection is a recognized cause of hypergastrinemia, but the association of blood gastrin levels with colonic adenomas (CAs) is controversial. The aim of this study is to investigate if hypergastrinemia, H. pylori infection and/or cagA protein are risk factors for CAs. Methods: In this prospective case-control study, fasting serum samples from 78 consecutive patients with CAs and 78 demographically matched colonoscopy-negative controls were assayed for anti-H. pylori immunoglobulin G, cagA protein and serum gastrin levels. Multivariate analysis was performed to identify risk factors for colon adenomas. Results: Though prevalence of H. pylori antibodies was not significantly different, the prevalence of cagA protein was significantly higher in patients with adenomas (42.3%) as compared with controls (25.6%, p < 0.03). Mediangastrin levels were significantly higher in patients with CAs (55, 20–975 pg/ml) than in controls (45.2, 23–529 pg/ml) (p < 0.001). Hypergastrinemia (>110 pg/ml) was commoner in patients with CAs than in controls (29.5 vs. 11.5%, p = 0.006) and was the only independent risk factor for adenomas (odds ratio 3.2, 95% CI 1.4–7.5) by multivariate analysis, but not H. pylori infection or cagA positivity. There was a significant association of hypergastrinemia and distal distribution of adenomas (p < 0.002). Conclusions: Our study shows that hypergastrinemia is a risk factor for CAs, especially of the distal colon.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Chronic hypergastrinemia, typically present during PPI use, can promote the growth of malignant colonic epithelial cells, facilitating the deleterious sequencing adenoma-carcinoma.
“Last, chronic hypergastrinemia, typically present during PPI use, can promote the growth of malignant colonic epithelial cells, facilitating the deleterious sequencing adenoma-carcinoma[151-153].”
From Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified (2019) · cites this paper as [153]
Cites
Suerbaum, S., & Michetti, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020542 · Cited by 2,984 · see citing works
Multiple Colorectal Adenomas, Classic Adenomatous Polyposis, and Germ-Line Mutations inMYH
Sieber, O. M., Lipton, L. R., Crabtree, M., Heinimann, K., Fidalgo, P. O., Phillips, R. K. S., Bisgaard, M.-L., Orntoft, T. F., Aaltonen, L. A., Hodgson, S. V., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025283 · Cited by 859 · see citing works
Forman, D., Debacker, G., Elder, J., et al. (1993) · Gut · doi:10.1136/gut.34.12.1672 · Cited by 467 · see citing works
Gastrin and colorectal cancer: A prospective study
Thorburn*, C. M., Friedman‡, G. D., Dickinson§, C. J., Vogelman∥, J. H., Orentreich∥, N., & Parsonnet*, #. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70193-3 · Cited by 267 · cited 1× · see citing works
“and that subjects with gastrin levels above normal limits have a 3.9-fold risk for CRC development [”
BackgroundInfluentialHelicobacter pylori infection in childhood: risk factors and effect on growth
Patel, P., Mendall, M. A., Khulusi, S., et al. (1994) · BMJ · doi:10.1136/bmj.309.6962.1119 · Cited by 260 · see citing works
Expression, processing, and secretion of gastrin in patients with colorectal carcinoma
Ciccotosto, G. D., McLeish, A. R., Hardy, K. J., & Shulkes, A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90572-3 · Cited by 186 · see citing works
Relationship between Helicobacter pylori CagA status and colorectal cancer
Shmuely, H., Passaro, D., Figer, A., Niv, Y., Pitlik, S. D., Samra, Z., Koren, R., & Yahav, J. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05342.x · Cited by 153 · see citing works
Gastrins, cholecystokinins and gastrointestinal cancer
Aly, A., Shulkes, A., & Baldwin, G. S. (2004) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2004.01.004 · Cited by 144 · see citing works
Helicobacter pylori Infection and Colorectal Cancer Risk: A Meta‐Analysis
Zumkeller, N., Brenner, H., Zwahlen, M., & Rothenbacher, D. (2006) · Helicobacter · doi:10.1111/j.1523-5378.2006.00381.x · Cited by 136 · see citing works
Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence
Smith, A. M., & Watson, S. A. (2000) · Gut · doi:10.1136/gut.47.6.820 · Cited by 106 · see citing works
Elevated gastrin levels in patients with colon cancer or adenomatous polyps
Smith, J. P., Wood, J. G., & Solomon, T. E. (1989) · Digestive Diseases and Sciences · doi:10.1007/bf01536047 · Cited by 104 · see citing works
Seroprevalence of helicobacter pylori in patients with colorectal polyps and colorectal carcinoma
Siddheshwar, R. K., Muhammad, K. B., Gray, J., & Kelly, S. B. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02148-1 · Cited by 103 · see citing works
Helicobacter pylori and the Risk of Colonic Adenomas
Breuer-Katschinski, B. D., Nemes, K., Marr, A., et al. (1999) · Digestion · doi:10.1159/000007661 · Cited by 101 · see citing works
Chronic endogenous hypergastrinemia in humans: Evidence for a mitogenic effect on the colonic mucosa
Laurent‐Puig, P., Sobhani, I., Lehy, T., Cadiot, G., Ruszniewski, P. B., & Mignon, M. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90006-x · Cited by 100 · see citing works
Helicobacter pylori infection, gastrin, cyclooxygenase-2, and apoptosis in colorectal cancer
Hartwich, A., Konturek, S. J., Pierzchalski, P., Żuchowicz, M., Labza, H., Konturek, P. C., Karczewska, E., Bielański, W., Marlicz, K., Starzyñska, T., et al. (2001) · International Journal of Colorectal Disease · doi:10.1007/s003840100288 · Cited by 96 · see citing works
High Prevalence of Helicobacter pylori Infection in Patients With Colonic Adenomas and Carcinomas
Meucci, G., Tatarella, M., Vecchi, M. L., et al. (1997) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199712000-00011 · Cited by 93 · see citing works
Watson, S., & Smith, A. M. (2001) · PubMed · Cited by 89 · see citing works
Helicobacter pylori related hypergastrinaemia is the result of a selective increase in gastrin 17.
Mulholland, G., Ardill, J. E. S., Fillmore, D., et al. (1993) · Gut · doi:10.1136/gut.34.6.757 · Cited by 82 · see citing works
Helicobacter pylori Seroprevalence and Colorectal Neoplasia: Evidence Against an Association
Moss, S. F., Neugut, A. I., Garbowski, G. C., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.10.762 · Cited by 74 · see citing works
Prewett, E. J., Smith, J., Nwokolo, C. U., Hudson, M., Sawyerr, A. M., & Pounder, R. E. (1991) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1991.tb00029.x · Cited by 69 · see citing works
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia
Renga, M., Brandi, G., Paganelli, G. M., Calabrese, C., Papa, S., Tosti, A., Tomassetti, P., Miglioli, M., & Biasco, G. (1997) · Gut · doi:10.1136/gut.41.3.330 · Cited by 66 · see citing works
Graham, D. Y., Go, M. F., Lew, G. M., et al. (1993) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529309098274 · Cited by 61 · see citing works
Penman, I. D., El-Omar, E. M., Ardill, J. E. S., McGregor, J. R., Galloway, D., O’Dwyer, P. J., & McColl, K. E. L. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90018-3 · Cited by 60 · see citing works
Postprandial hypergastrinaemia in patients with colorectal cancer.
Wong, K., Beardshall, K., Waters, C., Calam, J., & Poston, G. J. (1991) · Gut · doi:10.1136/gut.32.11.1352 · Cited by 60 · see citing works
Elevated Serum Gastrin Levels in Patients with Colorectal Neoplasia
Seitz, E., Giovannini, M. F., Gouvernet, J., & Gautheir, A. P. (1991) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199110000-00013 · Cited by 58 · see citing works
Mizuno, S., Morita, Y., Inui, T., Asakawa, A., Ueno, N., Ando, T., Kato, H., Uchida, M., Yoshikawa, T., & Inui, A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21280 · Cited by 57 · see citing works
Serum levels of gastrin in patients with colorectal neoplasia
Suzuki, H., Matsumoto, K., & Terashima, H. (1988) · Diseases of the Colon & Rectum · doi:10.1007/bf02552592 · Cited by 52 · see citing works
Yapp, R. G., Modlin, I. M., Kumar, R. R., Binder, H. J., & Dubrow, R. (1992) · Digestive Diseases and Sciences · doi:10.1007/bf01307566 · Cited by 48 · see citing works
Serum gastrin is not higher in subjects with colonic neoplasia.
Kikendall, J. W., Ar, G., Lh, S., & Bowen, P. E. (1992) · PubMed · Cited by 44 · see citing works
Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
Konturek, P. C., Konturek, S., Bielański, W., et al. (1999) · PubMed · Cited by 43 · see citing works
Progastrin and Cyclooxygenase-2 in Colorectal Cancer
Konturek, P. C., Bielański, W., Konturek, S. J., et al. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1019652224424 · Cited by 41 · see citing works
Rengifo-Cam, W., & Singh, P. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043383999 · Cited by 41 · see citing works
Multiple Colorectal Adenomas — Is Their Number Up?
Marra, G., & Jiricny, J. (2003) · New England Journal of Medicine · doi:10.1056/nejme030002 · Cited by 34 · see citing works
Müerköster, S. S., Isberner, A., Arlt, A., Witt, M., Reimann, B., Blaszczuk, E., Werbing, V., Fölsch, U. R., Schmitz, F., & Schäfer, H. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.06.059 · Cited by 34 · see citing works
Colorectal Adenomateous Polyps and Helicobacter pylori Infection
Aydın, A., Karasu, Z. A., Zeytinoğlu, A., et al. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01121.x · Cited by 28 · see citing works
Differential Responsiveness of Proximal and Distal Colonic Mucosa to Gastrin
Malecka-Panas, E. I., Fligiel, S., Jaszewski, R., & Majumdar, A. P. N. (1997) · Peptides · doi:10.1016/s0196-9781(97)00061-2 · Cited by 27 · see citing works
Seroepidemiology ofHelicobacter pyloriinfection in Greece
Patéraki, E., Mentis, A. F., Spiliadis, C., et al. (1990) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1990.tb03512.x · Cited by 26 · see citing works
Self-citationGastrin, growth, and colon neoplasia
Dockray, G. J. (2000) · Gut · doi:10.1136/gut.47.6.747 · Cited by 21 · see citing works
Houli, N., Loh, S.-W., Giraud, A. S., et al. (2005) · Regulatory Peptides · doi:10.1016/j.regpep.2005.10.001 · Cited by 15 · see citing works
Serum gastrin levels and colorectal neoplasia
Vanderstraeten, E., Vos, M. M. D., Versieck, J., et al. (1995) · Diseases of the Colon & Rectum · doi:10.1007/bf02052446 · Cited by 14 · see citing works
Serum gastrin levels in patients with colorectal cancer and adenomatous polyps: a prospective study.
Mihas, A. A., Maliakkal, R. J., Shueke, M. E., & Jl, A. (1995) · PubMed · Cited by 11 · see citing works
[Blood gastrin and colorectal neoplasms].
Civitelli, S., Galgani, P., Pacchiarotti, M. C., et al. (1994) · PubMed · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Proton pump inhibitors and dysbiosis: current knowledge and aspects to be clarified
Bruno, G., Zaccari, P., Rocco, G., Scalese, G., Panetta, C., Porowska, B., Pontone, S., & Severi, C. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i22.2706 · Cited by 258 · see citing works
- Authors
- Georgopoulos, S. D., Polymeros, D., Triantafyllou, K., Spiliadi, C., Mentis, A., Karamanolis, D. G., & Ladas, S. D.
- Affiliations
- National and Kapodistrian University of Athens (GR)
- Evangelismos Hospital (GR)
- Tzaneion General Hospital (GR)
- ORCID
- Ladas, Spiros D.
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2006
- Volume
- 74
- Issue
- 1
- Pages
- 42-46
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- OpenAlex
- W2082000793
- Cited by
- 90
- References
- 42
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 1 · 2023: 5 · 2022: 4 · 2021: 5 · 2020: 9 · 2019: 11 · 2018: 3 · 2017: 3 · 2016: 6 · 2015: 2 · 2014: 6 · 2013: 9 · 2012: 7
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Digestion (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Hellenic Society of Gastroenterology
- Topics
- Health Sciences › Medicine › Surgery › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- hypergastrinemia, colonic adenoma, Helicobacter pylori infection, CagA protein, serum gastrin, colorectal cancer risk factors, anti-H. pylori antibodies
- MeSH terms
- Adenoma, Adult, Aged, Aged, 80 and over, Antigens, Bacterial, Bacterial Proteins, Colonic Neoplasms, Female, Gastrins, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Multivariate Analysis, Case-Control Studies, Helicobacter pylori, Helicobacter Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review